Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes

We conducted a descriptive case study to examine the effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on urinary angiotensinogen excretion, which represents the function of the intrarenal renin–angiotensin system, in patients with type 2 diabetes. An SGLT2 inhibitor (canagliflozin 100 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimoto, Takuo, Furuki, Takayuki, Kobori, Hiroyuki, Miyakawa, Masaaki, Imachi, Hitomi, Murao, Koji, Nishiyama, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Investigative Medicine 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812257/
https://www.ncbi.nlm.nih.gov/pubmed/28596160
http://dx.doi.org/10.1136/jim-2017-000445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812257/
https://www.ncbi.nlm.nih.gov/pubmed/28596160
http://dx.doi.org/10.1136/jim-2017-000445

Ejemplares similares